Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials

Introduction The present study aims to evaluate the risk of pancreatic cancer with incretin-based therapy among patients with type 2 diabetes mellitus (T2DM). Methods We searched EMBASE, MEDLINE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for eligible studies published...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes therapy 2016-12, Vol.7 (4), p.725-742
Hauptverfasser:	Chen, Han, Zhou, Xiaoying, Chen, Tao, Liu, Bingtuan, Jin, Wujuan, Gu, Huiyuan, Hong, Tianyuan, Zhang, Guoxin
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Diabetes Drug therapy Endocrinology Internal Medicine Medicine Medicine & Public Health Meta-analysis Original Research Pancreatic cancer Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!